|
It was reported that a patient underwent an atrial fibrillation ablation procedure using a thermocool® smart touch¿ bi-directional navigation catheter.The patient experienced cerebrovascular accident that required thrombolytics and prolonged hospitalization.The procedure was performed on (b)(6) 2023.Post procedure, it was found in post operative anesthesia recovery that the patient had suffered a dual hemisphere stroke.The patient was given thrombolytics and has residual nero deficits and remained in the hospital.The physician noted no biosense webster inc.(bwi) product malfunctions.The physician's opinion on this adverse event was "interop issue not directly related to bwi products".Patient required a tracheotomy and "additional care".No evidence of char, thrombus/clot during the procedure.
|
|
The device has been reported as discarded, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.Manufacturing record evaluation (mre) cannot be conducted because no lot number was provided by the customer.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|